Literature DB >> 647115

Role of the hypophysis in erythropoietin production during hypoxia.

C Peschle, I A Rappaport, M C Magli, G Marone, F Lettieri, C Cillo, A S Gordon.   

Abstract

Hypophysectomized or sham-operated male rats were exposed to hypoxia (0.42--0.40 or 0.37--0.35 atm for 6, 12, or 24 hr) applied 2 wk to 7 mo after surgery. Erythropoietin (Ep) levels in rat serum were evaluated on the basis of the exhypoxic polycythemic mouse assay. Ep activity evoked by hypoxia was significantly lower in hypophysectomized rats than in sham-operated controls. Progressive increase of the EP response to hypoxia correlated with extension of the time interval between hypophysectomy and hypoxia from 2 wk to 2--4 mo apparently mediated by the simultaneous inverse decline of red cell mass (RCM) values, i.e., of the "relative plethora" induced by a low O2 demand associated with relatively high RCM values. However, after 3--7 mo hypoxic Ep activity was still lower than in sham-operated controls. In these ablated animals the relative plethora became negligible or absent; accordingly, the Ep response apparently had reached plateau levels. These studies indicate that hypophysis (hypophyseal and target hormones, with the exception of estrogens) modulates Ep production under hypoxic conditions, possibly via a permissive enhancement of renal Ep activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647115

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine.

Authors:  H Nishioka; J Haraoka
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

2.  Hematological response of pancytopenia to glucocorticoids in patients with Sheehan's syndrome.

Authors:  Bashir Ahmad Laway; Shahnaz Ahmad Mir; Javid Rasool Bhat; Mohd Iqbal Lone; Jeelani Samoon; Abdul Hamid Zargar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

3.  Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism.

Authors:  M Sohmiya; Y Kato
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

4.  Prevalence of hematological abnormalities in patients with Sheehan's syndrome: response to replacement of glucocorticoids and thyroxine.

Authors:  Bashir Ahmad Laway; Shahnaz Ahmad Mir; Mir Iftikhar Bashir; Javid Rasool Bhat; Jeelani Samoon; Abdul Hamid Zargar
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.